Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition
Crossref DOI link: https://doi.org/10.1007/s11523-014-0344-7
Published Online: 2014-10-25
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Coco, Simona
Truini, Anna
Alama, Angela
Dal Bello, Maria Giovanna
Venè, Roberta
Garuti, Anna
Carminati, Enrico
Rijavec, Erika
Genova, Carlo
Barletta, Giulia
Sini, Claudio
Ballestrero, Alberto
Boccardo, Francesco
Grossi, Francesco
Text and Data Mining valid from 2014-10-25